# A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules

> **NCT03340961** · PHASE2 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 205 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** DFD-29 Extended Release Capsules (40 mg)
- **DRUG:** DFD-29 Extended Release Capsules (20 mg)
- **DRUG:** Oraycea® (doxycycline) Capsules
- **DRUG:** Placebo Capsules

## Key facts

- **NCT ID:** NCT03340961
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-01
- **Primary completion:** 2018-11-07
- **Final completion:** 2019-03-31
- **Target enrollment:** 205 (ACTUAL)
- **Last updated:** 2021-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03340961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03340961, "A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03340961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*